期刊: MOVEMENT DISORDERS, 2021; 36 (8)
Background The accumulation of alpha-synuclein (alpha-Syn) aggregates that leads to the onset of Parkinson's disease (PD) has been postulated to begin......
期刊: MOVEMENT DISORDERS, 2021; 36 (6)
Background Wilson disease is a rare, disabling, neurological genetic disease. Biomarkers of brain damage are less well developed. Objective The aim of......
期刊: MOVEMENT DISORDERS, 2021; 36 (8)
Background Whole-genome sequencing data are available from several large studies across a variety of diseases and traits. However, massive storage and......
Background: Motor symptoms in Parkinson's disease (PD) patients might be related to high-level task-control deficits. We aimed at investigating the dy......
Background Autophagy is intensively studied in cancer, metabolic and neurodegenerative diseases, but little is known about its role in pathological co......
Background Regionalized thalamic activity has been implicated in language function, and yet the effect of thalamic deep brain stimulation (DBS) on lan......
期刊: MOVEMENT DISORDERS, 2020; 35 (4)
Background Heterozygous mutations in the glucocerebrosidase gene (GBA) have been shown to be an important genetic risk factor for Parkinson's disease ......
期刊: MOVEMENT DISORDERS, 2020; 35 (4)
Background Biallelic mutations in the MYORG gene were first identified as the cause of recessively inherited primary familial brain calcification. Int......
期刊: MOVEMENT DISORDERS, 2020; 35 (8)
Background Paroxysmal kinesigenic dyskinesia is a spectrum of involuntary dyskinetic disorders with high clinical and genetic heterogeneity. Mutations......
期刊: MOVEMENT DISORDERS, 2020; 35 (8)
Objective Accurate diagnosis is particularly challenging in Parkinson's disease (PD), multiple system atrophy (MSAp), and progressive supranuclear pal......